Goldman Reform Presentation
Goldman Reform Presentation
Goldman Reform Presentation
US Banks: Regulation
May 2010
Large Cap: Attractive
Regionals: Neutral
Trust Banks: Neutral
Consumer Finance: Neutral
The Goldman Sachs Group, Inc. does and seeks to do business with companies covered in its research reports. As a result, investors should be aware
that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in
making their investment decision.
For Reg AC certification, see the end of the text. Other important disclosures follow the Reg AC certification, or go to www.gs.com/research/hedge.html.
Analysts employed by non-US affiliates are not registered/qualified as research analysts with FINRA in the U.S.
Regulation
MOST POTENTIAL
OVERALL RISK --> NEGATIV LESS AT RISK MODEST
E RISK POSITIVES
House Senate
Senate Floor
(April/May 2010)
Option 1: Conference Committee
House-Senate Conference
Committee
(May/June 2010)
House Passage of Conf. Senate Passage of Conf.
Report (June 2010) Report (June 2010)
Difficult to see how exchange and clearing stocks are not incremental beneficiaries
CME: currently trades and clears 99% of U.S. futures products on interest rates
NDAQ: acquired the International Derivatives Clearing Group (IDCG) in 2009, which is
the only market participant to have announced it has an interest rate swap clearing
platform ready for clients to test
Dealers/Brokers have less directional authority to drive clearing strategy than they have had
in the past few years
ICE Trust is the dominant provider of clearing services in CDS clearing in the U.S.
Dealers were able to secure 49% of net profits from ICE Trust to support that platform
NYSE – sold 49% stake in its U.S. options business to attract flow
Beyond clearing, there could be positive impacts on transactions and associated exchange
traded product
Clearing tends to have a higher profit stickiness given underlying liquidity pool
Other market structure names may benefit: GFIG, BGCP, MKTX, NITE
$700 684
596 604
$600
516
592
since 1998
$500
$400 370
414
• Interest Rate swaps have grown the
297
$300
220
257
281
fastest at 26% and represent 72% of total
$200 197
169
$100 72 80 81 88 94 95 99 111
127 141
• CDS swaps are now $25 tn
• But exchange traded products turn over
$0
1H98
2H98
1H99
2H99
1H00
2H00
1H01
2H01
1H02
2H02
1H03
2H03
1H04
2H04
1H05
2H05
1H06
2H06
1H07
2H07
1H08
2H08
1H09
much more rapidly
100 93.0x 92.0x
90
80
500
Interest rate and F/X OTC markets are multiple of exchange peers 70
450 437.2
60
6.5x 50 45.0x
400
40
350
30 21.2x
300 20 11.9x
10 4.5x 2.8x
0.6x 1.2x 1.1x 1.0x
250
0
200 Total FX FX Swaps FX Total FRAs IRS IR F/X Rate Equity
Forward Options Options Futures Futures Futures
150 F/X OTC Interest Rate OTC Exchange Traded
100
67.1
48.8 157x
50 1.2x
6.6 5.8 0.3
-
Interest Rate Equity Index F/X
Dealer to $16 Cumulative Single Name Notional Outstanding ($ tn) Cumulative Notional % Outstanding 120%
Client $14
100%
23%
$12
80%
$10 Average Years to Sw ap
Term ination: 2.7 years
$8 60%
$6
40%
$4
20%
$2
Dealer to
$0 0%
Dealer
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
77%
US dollar
35%
Total Global Interest Rate Swap • The interest rate swap market is the focus of
Market: the next leg of clearing. It represents 72% of
$437 tn the global OTC market
Dealer to Client Notional $38,541,750,000,000 This is the sector CME, NDAQ are pursuing
Number of 'one $ mn units' 38,541,750 Assumes full backloading, probably takes 4-7 years to reach this level
PNC $115MM after-tax impact in 2010 (half year impact) 0.35 1.0 37% COF Margin to decline to 15% from 17% currently $0.93 $5.00 19%
USB $200MM-$300MM impact in 2010 0.25 1.0 26% DFS Margin to decline by 25-50 bps from 2009YE $0.30 $2.00 15%
BAC about $2.0BN / quarter run rate vs $2.57BN currently 2.00 11.0 18% AXP Margin to decline to 9% from 10% currently $0.34 $3.15 11%
KEY $50MM on an annualized basis 0.05 0.3 15% BAC $900MM after-tax annual impact $0.09 $2.40 4%
STI reduction of 10-20% during the 2H of the year 0.13 0.8 15% JPM $500-$750MM net income reduction $0.15 $6.50 2%
JPM $500MM +/- annualized after-tax impact 0.77 5.6 14% C $400-600MM pre-tax annual net impact $0.01 $0.45 2%
WFC $500MM after-tax annualized impact 0.77 5.7 13% PNC $40MM after-tax annual impact $0.08 $6.50 1%
FITB $20MM / quarter by 4Q09 0.08 0.6 13% USB $100MM pre-tax impact in 2010 $0.03 $2.85 1%
BBT $70-$80MM pre-tax annual impact 0.08 0.7 11% WFC $235MM after-tax gross impact $0.05 $4.35 1%
Average 16%
Capital ratios back to pre-crisis levels 50% of banks have >8% Tier 1 common
13.0%
TCE / TA Tier 1 Common
Tier 1 Common STT 15.9%
12.0% Tier 1 Ratio NTRS 12.8%
BK 11.6%
11.0% ~11.0% COF 10.7%
50% above FHN 9.9%
8% CMA 9.6%
10.0% CYN 9.4%
C 9.1%
US Banks Capital Ratios
JPM 9.1%
9.0% BBT 8.7%
WAL 8.2%
~8.3%
8.0% MS 8.2%
8.0%
STI 7.7%
7.0% BAC 7.6%
PNC 7.6%
KEY 7.5%
6.0% MI 7.5%
~5.8% 100%
FNFG 7.5%
above 6%
RF 7.1%
5.0%
USB 7.1%
WFC 7.1%
4.0% ZION 7.0%
FITB 7.0%
HBAN 6.5%
3.0% 6.0%
Simple Avg 8.8%
1Q91
2Q92
3Q93
4Q94
1Q96
2Q97
3Q98
4Q99
1Q01
2Q02
3Q03
4Q04
1Q06
2Q07
3Q08
4Q09
310
190
170
150
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
Source: Company data, SNL, Goldman Sachs Research estimates.
Goldman Sachs Global Investment Research 23
Credit availability and liquidity
Less interest rate hedging = more volatile
mortgage rates relative to 10yr UST
450bps Average
+1SD
400bps -1SD
Standard Deviation
350bps 1970 - 1989 70
1990 - Now 32
300bps
250bps
224bps
200bps
170bps
150bps
134bps
116bps
100bps
50bps
0bps
Jan-72
Jan-73
Jan-74
Jan-75
Jan-76
Jan-77
Jan-78
Jan-79
Jan-80
Jan-81
Jan-82
Jan-83
Jan-84
Jan-85
Jan-86
Jan-87
Jan-88
Jan-89
Jan-90
Jan-91
Jan-92
Jan-93
Jan-94
Jan-95
Jan-96
Jan-97
Jan-98
Jan-99
Jan-00
Jan-01
Jan-02
Jan-03
Jan-04
Jan-05
Jan-06
Jan-07
Jan-08
Jan-09
Jan-10
Source: Federal Reserves, Freddie Mac, Goldman Sachs Research estimates.
Goldman Sachs Global Investment Research 25
As private sector credit shrinks, loans are
shifted to the government balance sheet
500 100%
US Resi Real Estate Credit - YoY Change, $bn
300 80%
200 70%
100 60%
0 50%
-100 40%
-200 30%
-300 20%
-400 10%
0%
-500
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
1Q09
2Q09
3Q09
Gov't incl GSEs Bank Loans Non-banks + securitization
Note: Loan shrinkage data cited here differs from similar data points cited on p14 and p24 as this data point is sourced from Federal Reserve- Flow of Funds data while p12 and
p28 data points are derived from the Federal Reserve- H-8 data
Source: Industry sources, Goldman Sachs Research.
Goldman Sachs Global Investment Research 26
Banks – possible risks to normalized EPS
Significant range of EPS outcomes depending
on legislation
EPS risk: from small plus to -20% Estimate risk vs valuation gap to history
20%
Potential Earnings
Potential % Factored in to
Estimate
Earning Impact Estimates
Upside/Downside
10%
Asset Managers
Exchanges 7% 0% 7%
0%
Asset Managers 5% 0% 5%
-40%
A positive that may
not be fully
factored in
-50%
-25% -20% -15% -10% -5% 0% 5% 10%
Potential Earnings Estim ate Upside/Dow nside from Reg Reform
We estimate the market discounts about an 80% chance of worst case scenario
100.0%
77%
80.0%
Financial Regulatory Reform *
Market Implied Probability of
60.0%
40.0%
20.0%
0.0%
-20.0%
-40.0%
01/01/10
01/08/10
01/15/10
01/22/10
01/29/10
02/05/10
02/12/10
02/19/10
02/26/10
03/05/10
03/12/10
03/19/10
03/26/10
04/02/10
04/09/10
04/16/10
04/23/10
04/30/10
*: defined as underperformance of big banks relative regionals, credit cards and small brokers divided by the incremental earnings from
regulatory reforms to big banks relative to the other sectors
Incremental risk to
TARP Tax 4% No 20.4% 1.8% 12.4%
normalzed EPS
Prop Restriction 3% No
*: BAC, C, JPM and MS.
Liability Caps 2% No **: assuming CARD Act and Reg E are mostly modeled in.
Derivatives Legislation 4% No
After-tax Impact 6.0 4.9 5.5 1.9 1.1 0.3 0.3 0.3 0.1 0.2 0.5 0.5 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0
S/O (bn) 9.9 29.9 4.0 1.4 5.2 0.5 1.9 1.2 0.2 0.5 1.2 0.5 0.5 0.7 0.1 0.2 0.8 0.2 0.2 0.5 0.7 0.9 0.5 0.4 1.2 0.5 0.1 0.16
"Gross" EPS hit $0.61 $0.16 $1.38 $1.34 $0.21 $0.62 $0.17 $0.21 $0.38 $0.38 $0.41 $1.14 $0.32 $0.13 $0.13 $0.24 $0.09 $0.09 $0.02 $0.04 $0.05 $0.05 $0.05 $0.00 $0.07 $0.24 $0.01 $0.20
% of Normalized EPS 25% 33% 21% 30% 5% 10% 6% 8% 11% 12% 11% 23% 16% 4% 3% 5% 6% 7% 1% 3% 9% 5% 8% 0% 9% 7% 3% 9% 18%
(1): estimated using 15% of annual deposit servicing charges (5% for trust banks), similar to banks that provide guidance.
(2): estimated where not provided.
(3): estimated using 15bps of Total Assets - Tier 1 Capital - FDIC-assessed deposits - UST Repos. Assuming USB reports make up 80% of total repo outstanding.
(4) assuming 10% decline in b/s size for big 3 banks. Also assuming 10% for trust banks as they reduce the repo books.
(5): using disclosed % of revenue by bank where applicable.
(6): for JPM using guidance of $2.0-$3.0bn pre-tax; others estimated as % of gross derivatives.
Provision expense 7.0 3.7 1.1 11.7 Provision expense 4.4 3.3 0.4 0.1 8.1
Noninterest expense 8.0 2.0 6.4 16.3 Noninterest expense 5.2 1.3 4.3 2.6 13.5
Pre-tax income -2.1 -1.6 4.3 -1.6 Pre-tax income 2.5 -1.1 3.0 1.2 5.5
Taxes -0.8 -0.6 1.6 -0.6 Taxes 1.1 -0.4 0.9 0.4 2.0
Tax rate 40% 36% 36% 39% Tax rate 43% 37% 31% 37% 36%
Net income -1.3 -1.0 2.7 -1.0 Net income 1.4 -0.7 2.1 0.7 3.5
Total assets 1,237 224 885 2,345 Total assets 1,161 192 679 93 2,125
Total loans 702 208 99 1,009 Total loans 450 169 66 52 738
Adjustment Adjustment
Revenue run rate 12.9 4.0 11.7 28.6 Revenue run rate 11.3 3.5 7.7 3.9 26.3
Normalized provision rate 0.50% 3.00% 0.10% 0.98% Normalized provision rate 0.50% 3.00% 0.10% 0.00% 1.00%
Normalized provision ($) 3.5 6.2 0.1 9.8 Normalized provision ($) 2.3 5.1 0.1 0.0 7.4
Normal efficiency 50% 40% 70% 57% Normal efficiency 50% 40% 70% 70% 14.8
Assumed efficiency * 55% 44% 77% 62% Assumed efficiency * 55% 44% 77% 77% 63%
Annual Pre-tax 19.6 2.8 10.7 33.1 Annual Pre-tax 18.1 2.7 7.0 3.6 31.3
Tax rate 35% 35% 35% 35% Tax rate 35% 35% 35% 35% 35%
Preferred dividend 2.6 0.0 0.0 2.6 Preferred dividend 0.0 0.0 0.0 0.0 0.0
Net income 10.2 1.8 6.9 18.9 Net income 11.8 1.7 4.5 2.3 20.4
ROA 0.8% 0.8% 0.8% 0.8% ROA 1.0% 0.9% 0.7% 2.5% 1.0%
Multiple 10.0x 10.0x 10.0x 10.0x Multiple 10.0x 10.0x 10.0x 15.0x 10.6x
Value 102 18 69 189 Value 118 17 45 35 215
Value per share $11.8 $2.1 $8.0 $21.8 Value per share $29.8 $4.4 $11.6 $8.8 $54.6
*: assuming expenses are 10% higher due to the cost of running businesses separately.
Note: Note:
Commercial Bank includes Deposits, Home Loans & Insurance and Global Commercial Banking. Commercial Bank includes Retail Financial Services and Commercial Banking.
Investment Bank includes Global Corporate & IB, Global Markets and GWIM. AM & Trust includes Asset Management and Treasury & Securities Services.
Corporate segment is allocated to each segment. Excluding $2.2bn of MER CVA. Corporate segment is allocated to each segment.
We, Richard Ramsden, Brian Foran and Daniel Harris, hereby certify that all
of the views expressed in this report accurately reflect our personal views
about the subject company or companies and its or their securities. We also
certify that no part of our compensation was, is, or will be, directly or
indirectly, related to the specific recommendations or views expressed in
this report.
A s of A pril 1, 2010, Goldman Sachs Global Investment Research had investment ratings on 2,821 equity securities. Goldman
Sachs assigns stocks as Buys and Sells on various regional Investment Lists; stocks not so assigned are deemed Neutral.
Such assignments equate to Buy, Hold and Sell f or the purposes of the above disclosure required by NA SD/NY SE rules. See
'Ratings, Coverage groups and view s and related def initions' below .
Regulatory disclosures
Additional disclosures required under the laws and regulations of jurisdictions other than the United States
The following disclosures are those required by the jurisdiction indicated, except to the extent already made above pursuant to United States laws and regulations.
Australia: This research, and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act. Canada: Goldman Sachs & Co. has
approved of, and agreed to take responsibility for, this research in Canada if and to the extent it relates to equity securities of Canadian issuers. Analysts may conduct site visits but are
prohibited from accepting payment or reimbursement by the company of travel expenses for such visits. Hong Kong: Further information on the securities of covered companies
referred to in this research may be obtained on request from Goldman Sachs (Asia) L.L.C. India: Further information on the subject company or companies referred to in this research
may be obtained from Goldman Sachs (India) Securities Private Limited; Japan: See below. Korea: Further information on the subject company or companies referred to in this
research may be obtained from Goldman Sachs (Asia) L.L.C., Seoul Branch. Russia: Research reports distributed in the Russian Federation are not advertising as defined in the
Russian legislation, but are information and analysis not having product promotion as their main purpose and do not provide appraisal within the meaning of the Russian legislation on
appraisal activity. Singapore: Further information on the covered companies referred to in this research may be obtained from Goldman Sachs (Singapore) Pte. (Company Number:
198602165W). Taiwan: This material is for reference only and must not be reprinted without permission. Investors should carefully consider their own investment risk. Investment
results are the responsibility of the individual investor. United Kingdom: Persons who would be categorized as retail clients in the United Kingdom, as such term is defined in the rules
of the Financial Services Authority, should read this research in conjunction with prior Goldman Sachs research on the covered companies referred to herein and should refer to the
risk warnings that have been sent to them by Goldman Sachs International. A copy of these risks warnings, and a glossary of certain financial terms used in this report, are available
from Goldman Sachs International on request.
European Union: Disclosure information in relation to Article 4 (1) (d) and Article 6 (2) of the European Commission Directive 2003/126/EC is available at
http://www.gs.com/client_services/global_investment_research/europeanpolicy.html which states the European Policy for Managing Conflicts of Interest in Connection with Investment
Research.
Japan: Goldman Sachs Japan Co., Ltd. is a Financial Instrument Dealer under the Financial Instrument and Exchange Law, registered with the Kanto Financial Bureau (Registration
No. 69), and is a member of Japan Securities Dealers Association (JSDA) and Financial Futures Association of Japan (FFAJ). Sales and purchase of equities are subject to
commission pre-determined with clients plus consumption tax. See company-specific disclosures as to any applicable disclosures required by Japanese stock exchanges, the
Japanese Securities Dealers Association or the Japanese Securities Finance Company.
General disclosures
This research is for our clients only. Other than disclosures relating to Goldman Sachs, this research is based on current public information that we consider reliable, but
we do not represent it is accurate or complete, and it should not be relied on as such. We seek to update our research as appropriate, but various regulations may prevent
us from doing so. Other than certain industry reports published on a periodic basis, the large majority of reports are published at irregular intervals as appropriate in the
analyst's judgment.
Goldman Sachs conducts a global full-service, integrated investment banking, investment management, and brokerage business. We have investment banking and other
business relationships with a substantial percentage of the companies covered by our Global Investment Research Division. Goldman Sachs & Co., the United States
broker dealer, is a member of SIPC (http://www.sipc.org).
Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients and our proprietary trading desks
that reflect opinions that are contrary to the opinions expressed in this research. Our asset management area, our proprietary trading desks and investing businesses
may make investment decisions that are inconsistent with the recommendations or views expressed in this research.
We and our affiliates, officers, directors, and employees, excluding equity and credit analysts, will from time to time have long or short positions in, act as principal in, and
buy or sell, the securities or derivatives, if any, referred to in this research.
This research is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It does not
constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Clients should
consider whether any advice or recommendation in this research is suitable for their particular circumstances and, if appropriate, seek professional advice, including tax
advice. The price and value of investments referred to in this research and the income from them may fluctuate. Past performance is not a guide to future performance,
future returns are not guaranteed, and a loss of original capital may occur. Fluctuations in exchange rates could have adverse effects on the value or price of, or income
derived from, certain investments.
Certain transactions, including those involving futures, options, and other derivatives, give rise to substantial risk and are not suitable for all investors. Investors should
review current options disclosure documents which are available from Goldman Sachs sales representatives or at
http://www.theocc.com/publications/risks/riskchap1.jsp. Transactions cost may be significant in option strategies calling for multiple purchase and sales of options such
as spreads. Supporting documentation will be supplied upon request.
All research reports are disseminated and available to all clients simultaneously through electronic publication to our internal client websites. Not all research content is
redistributed to our clients or available to third-party aggregators, nor is Goldman Sachs responsible for the redistribution of our research by third party aggregators. For
all research available on a particular stock, please contact your sales representative or go to http://360.gs.com.
Disclosure information is also available at http://www.gs.com/research/hedge.html or from Research Compliance, 200 West Street, New York, NY 10282.
Copyright 2010 The Goldman Sachs Group, Inc.
No part of this material may be (i) copied, photocopied or duplicated in any form by any means or (ii) redistributed without the prior written consent
of The Goldman Sachs Group, Inc.